Scribd Logo
Hochladen

Willkommen bei Scribd!

  • Craig R. Travis - Cannabinol Derivatives

    Hochgeladen von

    RoundSTIC
    21 Ansichten26 Seiten

    Originaltitel

    Craig R. Travis- Cannabinol Derivatives

    Copyright

    © Attribution Non-Commercial (BY-NC)

    Verfügbare Formate

    PDF oder online auf Scribd lesen

    Stufen Sie dieses Dokument als nützlich ein?

    Sind diese Inhalte unangemessen?

    Dieses Dokument melden

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Als PDF herunterladen oder online auf Scribd lesen
    Markieren Sie unangemessene Inhalte
    21 Ansichten26 Seiten

    Craig R. Travis - Cannabinol Derivatives

    Hochgeladen von

    RoundSTIC

    Copyright:

    Attribution Non-Commercial (BY-NC)
    Als PDF herunterladen oder online auf Scribd lesen
    Markieren Sie unangemessene Inhalte
    von 26
    2) United States Patent ‘Travis ‘USOOTLOS68SB2 US 7,105,685 B2 Sep. 12, 2006 (10) Patent No. (4s) Date of Patent: (34) CANNABINOL DERIVATIVES (96) Inventor: Craig R. Travis, $901 SW. 87" St, South Miami, FL (US) 33143 () Notice: Subject wo any diteluimer the tem of this patent is extended or adjusted under 35 USC. 154(b) by 83 days (21) Appl. Now 10/928,242 (22) Filed: Dee, 22, 2002 6s) Prior Publication Data {US 20080158191 AL Avg, 21, 2003 Related U.S. Application Data (63) Continuation of appiaton No, 09928685, fed on Aus. 1,200, mow Pat No.6 506,560 which 3 entiation: inp of appicion No. 09'S88385, ied on Mie Bon, now Pat No. 8278835, (G0) Provisional splication No. 60125674 ied on Mat. 2, 199, and provisional application No, 60151595, fled on Aug. 30. 199, (1) Incl. C7 31180 (2006001) Cord 3114 (2006.01) €or 31178 (2006.01) (2) US. ‘549/990; 49/200, 5491356; ‘49/381; 540/385; 549/388; 549/389, 549/391 (58) Fleld of Classitication Search S6WTIS, ‘68/716, 731, 732, 733; 549/200, 356, 381, ‘49/385, 388, 390 X, 380, 391 See application file for complete search history. 66) References Cited US. PATENT DOCUMENTS. $65527 A 101896 Adame 2308669 A 12/1982 Adame Dsw.a86 A 51950 Adan S386 A 61968 Taster SSOTSES A 411970. Fahenbole 31972. Ravfnn eta 1972 Petia + 34974 Loev ea 23483 * 2174 Loew dass 11974 Loew SADIE Bender eta osonon 6013483 38ol402 A 21975 Fager tal 387.876 AMOS Palla 38973105 A TIDIS Vidi ta 3019322 A 111975 Bross et BoINSOR A L2I97S Atcher UIT 41977 Brown et OIRT77 A 41977. Zag et $020098 841977 Goto 0S4SK3 A 101977 Blanchard Seto 121977 Fukuda sta AUS7S45 —BIDTH Archer et a a 81978 Fok oa (6 STS Reaan ot 440701 421979 Ryan (Continved FOREIGN PATENT DOCUMENTS ep 494 665 BL V1992 HU 18829 B 31986 2 o.t010%6 411990 » “4208280 A 11/1990 » 2000191520 872000 Wo WOUTIIGE A 41997 WO WOoT0006 8 101997 WO Wov920266 AL 4199 WO WO9932107 AL__T1999 WO WO9SISHO AL 10199 WO WOosrs24 A 19199 WO WO90S017 A 10199 (OTHER PUBLICATIONS Yoshida etal, Chem. & pharmaceutical Bulle 2), pp. 335-337; abstract only. Pitt et al. 1. Org: Chem, 1979, 445), pp. 677-683. Beak et al, rch Pharmacal Res, 19, 228-230, 1996, Beak et al, sch Pharmacal Res, 21(3), 383-356, 1998 Beutler et ai, J. Nar. Prod. 61, 1809-1812, 1998, Bhargave, General Pharm.” 9, 195-213, 1978. Burstein etal. Biochemicul Pharmacology, 29, 2183-2156, 1980. Cabral et a, Ade Biosci, 80, 93-105, 1991 Carchman et al, Marihuana Chem, Biochem. Cell Ef, Proc. Saell. Symp., 392-345, 1976, Elkin et al. Federation of American Societies for Experi ‘mental Biology. 71 Annual Meeting, Abstracts of Papers, Mar. 29 to Apr. 2, 1987, Haris etal, Pharm. Of Marihuana, 749-762, 1976. Hartman et al, J Med, Chem, 23, 881-848, 1980, Kawakami etal, dnt J. Immunopharmacol. 10, 485-488, 198s, Iyman et al, Joursal of Neuroimmunologs, 12, 73-81, 1989. Nahas et al, CR. Hebd, Seances Acad, Sol, 279(19), 1607-1608, 1974, Nichols et ab, Life Sciences, 21, 1245-1248, 1977. Signh etal, J. Org. Chem, 61, 7727-7737, 1996, Specter etal, Federation of American Societies for Experi ‘mental Biology. 4. A1021, 1980. Spocter et a, Druge of Abuse and Immune Function, 75-86, 1990. Srivastava etal, mmunopharmacofogr, 40, 179-185, 1998. Timpone etal, tds Res. Hom. Retroviruses, 13, 305-315, sor. ‘Waksman, Journal of Autoinmamity, $6, 1999. Wata etal, Jat. J. Immunopharmacol, 1091-1097, 1991 Wat etal, Ads Exp. Med. Biol, 288, 63.70, 1991 Zeng et al, Int. J. Dmumopharmacol, 14, 1445-1452, 1902. Zuri eta, Arthritis & Rheumatism, 41, 168-170, 1998, ‘Abrams, J- of deg. Immus. Def. Syn 25, 74-80 (2000) (Coutinved) (1995), 8 Primary Esaminer—Elvis 0. Price (74) Auornes, Agent, or Firm—Ash Tank, on ABSTRACT ‘The invention provides eannahinol derivatives ad pharma. ceutical preparations thereof. 6 Claims, No Drawings US 7,105,685 B2 Page 2 U.S. PATENT DOCUMENTS. SishasT 51638530, 51997 Tio ea 1997 Mechoslam ot al 31998 Leet 1908 Callin et S817651 A 101998 DrAmbra a ES24688 A 101908 Kalish et SRA7.128 A 12/190 Matin tl SRATI65 A 121998 Loe tal S856323 A 1/1999 Cai eal S839.067 A 1/1999. Rowfogais a. S872.148 A 2/1909 Maksjanns eta Ssoide A 411999 Amtem S916 365 A 6'1999 Bene ea 5925768 A 7/1999. Banh eta 181999. Shoham ta. $1999 Kuno et 911909 Render al 1/1999 Delia alle ota 1/2000 Rial ta 42000, Meyer e 9000 Pak ea 48.1398 1979 Bindi 480669 121979 Winn SU9S078 A “H1980 Conine 420.027 A 21981 Goto 443004885 411982 Johnson SBIS862 A 21982 Elsohly etal 43560 & 91982 Pine 4408626 & 911983 Johnson S608 A RID84. Husain 415003327 A T1986. Noga ot ‘4601505 41987 Marshall ta 4758397 8 TIDS8. Martine a 4577298 A 10/1988 Marshall ta SSHLOTS A SIBSD. MeNally ta 4837228 61989 Elsohly etal. AS4L078 A GID80 Eggler etal. X Su1989 tin A 1018 Mecho ca AD8368 A 61990. Sstsinger ea. 497.603 1171990 Bustin 112800 A 5/1002 Ward 5227537 A 711993 Sooke S250551 A 101993 Mien ta SSw759 A “¥1904 rstein et Sha971 A 8004 Herta S30.375 A 21995 Elohly 51440052 A 81995 Maksyannis ta Sao8419 A 1900 Par SSani9e A $1996 Zucksaman 5527819 A 611996 Williams eta Ss32257 A 71996 Gallant ea Si0s906 A 21997 Law 51605928 A 21907 Mechoulam etal Sgn4od1 A 4/1907 Banh eta a a a a a a a a a a a eutesr (OTHER PUBLICATIONS Adams, etal, J. Med Chem, 70, 662-68 (1947), Adams et al. “New Analogs of Tetraydrocannabinl,” 71 1624-28 (1949), Akamanchi etal, Pharm, Pharmacol. Commun. $,323-329 (1999), Arisawa et al, Chem. Pharm. Bull, 37, 9, 2431-2434 (1989), Baeverle et al, lnm, Rex: Immunol, 12, 141-79 (1994) Barth, Exp. Opin. Ther Patents, 8, 3, 01-313, (1998). Bennet etal, Marihuana and Medicine, 717-721 (Humana Press 1999), Biswas et al, J. of dog. loumun. Def. Sym and Hum, Retrovirol, 18, 426-34 (1998), Bomhcim, Biochem. Pharm., 36, 985-961 (2000). Pombeim, “Cansabidiol Effet on Cytochro PASO Isozymes,” Abstract, ILI Grant No. SROIDADS265-13, Bombeim, Chem. Res. Tasicol, UL, 1209-16 (1998), [Baitsein etal, AIDS 2001, 15, 4, 532-533 (2000), Brunneisen et al. Int J. of Clin Pharmacol. Ther, 34, 446-52 (1996), Buchwald etal, Pharamacie, 5S, 196-201 (2000), Burstein otal, J. Pharmacol. and Fxperimemtal Therapew- ties, 51, 2, 581-535 (1989) Burstein etal, Pharmacol. Ther, 82, 81-96 (1909), Tuseh-Petersea etal, J. Med. Chem.» 39, 3790-96 (1996). Bustos etal, J. Clin vest, 100, §, 1150-1158 (1997), Butlers et a Aide Res. Hum, Retrovir, 8, 991-95 (1992), Charalambous etal, Pharm Biochem. Behav, 40, $09-12 991), Chea etal, Chem. Commun., 2769-2770 (1998), Colasanti eta, Exp. Eye Res., 38, 63-71 (1984), CColasanti etal, Exp. Eye Res., 39, 251-259 (1984), Corr etal, "Selected metabolic alterations in the ischemic ‘bert and their contributions to arraythmogenesis." Abstract, NIH Grant No, 7543431 0198362134 Daaka etal, DNA Cell Biol, 16, 301-09 (1997), el Real eta, AIDS. 12, 865-72 (1998. Desoize, Anticancer Res. 14, 2291-94 (1994). Dewhirst, Prostaglandins, 20, 209-22 (1980), Di Franco, AEP, 6, 283-89 (1996). Dol etal, Fur Jt Ong. Chem, 389-64 (1998). Dominianai et al, J Org. Chem., 42. 344-46 (1977). Dumais et al, J Bio! Chem, 42, 27306-14 (1998). Eisohly etal of Pharm. Sciences, 71, 12, 1319-1323 (1982), Evans etal, Biochem. Pharm.. 36, 2088-37 (1987), Folder etal, Mol. Pharmool., 42, 838 48 (1992), Fiddler et al, Supp. I Circulation. 81,1, 1-69-1-78 (1990) Formukong e& al. Dept of Pharm, School of Pharm. University of London, 79P Nbstract. Ponmukong et al, Pharm. Pharmacol, 4 (1989), Faye otal, Prine: Med. Chemistry, ourth Eition, 246-98 (Williams & Wilkins 1995), Plirstner etal, J. Org. Chem., 62, 2832-36 (1997), Gallly et al. JL Pharmacol. R'sp. Ther, 283, 918-924 1997) Galve Roper etal, Naz Med. 6, 313-19 (2000), Garvan et al, Bioorg. Med. Chem. Let, 6, 189-4 (1996), Gervaix etal, Proc. Natl Acad. Sei (U.S.A. 94, 4653-58 «1997, Gollapudi et al, Aids Res. Hum. Reirovir, 14, 499-504 (1998), Gorter etal, Cannabis in der Behandlung krebsirander and HIV-positiver Patienten Die erste Kinische Cannabis ‘Studie in Deutschland, Brohanf Syzuposium, 691-92 (1997) (vith translation) Granelli-Piperno e ab, Proc. Natl Acad. Sei. (U.S.A), 92, 1094448 (1995) Grillin et al, Br J. Pharmacol, 126, 1575-84, (1999), Gruol, “Drug Facts on Nouronal Development in Pediatric Aids," Abstract NIH Grant No. IROIDATOL87-O1A2, Gurwivz etal, Molecular Medicine Today, May, 196-200 (1998) Hammer et al, The Scientist, 13, Feb. 15, 1999. 708-709 US 7,105,685 B2 Page 3 Hanis et al, The Pharmacologist, 17, 2, Abstract 492 (1975), Harvey ot al, Biomed. Mass Spect, 4, 364-70 (1977). Hembree Ill et al, Marihuana and Medicine, (1999), Herring et al, Biochem. Pharmacol. $5, 1013-23 (1998), ladyszowski otal, Free Rad. Res,, 28, 359-68 (1997), Huang etal, Marihuana and Medicine, (1999). Hulman, “Synthesis “of Cannabinoids Analogues and Metabolites” Abstrct, NIH Grant No. SRO1DA03590-11 Hollman etal, Bloor Med. Chem. 6, 2383-96 (1998). Huflman etal, Bioorg. Med. Chem. 6, 2281-88 (1998). Hofman et al, J. Med. Chem,. 39, 3875-77 (1996), Hiufiman etal, Lyfe Set, $6, 2021-24 (1998), Tokawa et al, Chem. Pharm. Bull, 35, 7, 3016-3020 (ass, Jobin et al, Thromb, Diath, Haemorrh, 22, 3, 466-481 (4969), Joy etal, “Consequences of Marijuana Use and Abuse." ia ‘Mariana and Medicine, 115-21, (National Academy Press, 1999. Kalofoutiset al, Pharm. Biochem. & Behavior, 12, 697-699 (1979), Kaminski, J. Neuroimmunol, 83, 124-32 (1998), Kaminski, Toviev! Ler, 102108, 59-63 (1998). Kapeghian etal, Gen. Pharmacol, 14, 3, 361-363 (1983). Khanotkar etal, Chem and Physics of Lipids, 18, 37-82 (2000, Kitagawa et al, Chem, Pharm, Bull, 39, 4, 1062-1064 (199), Klein etal, J. Newrolmmunol, 83, 102-15 (1998) Koch e€ al. Shmesis of $-Ailylresorcnols, (Unclassified Report) (1962), Konubek eal, Chem Revs, 99, 1-25 (1999. Lanez etal, Proc. Soe. Exp. Biol. Med 4, 401-« Lembenger et al (1973), Liddle etal, Bioorg. Med. Chem. Let. 8, 2223-26 (1988). Lpev etal, J Med. Chem. 11, 1234-35 (1974). Loev et al, J; Med Chem, 16, 1200-06 (1973). Lytolls etal, J. Am. Chem. Soe, 117, 12683-90 (1995). Madani etal, Proc. Nath, ded. Sci, (U.S.A. 95, 8005-10 (1998), Mahadevan etal. J. Med, Chem, 43, 3778-3785 (2000) Makriyannis ota, Life Soi, 47, 2173-84 (1990) Main etal, Pharm. Biochem. Behav, 46, 295-301 (1983). Matsuyama etal, AIDS, 5 1405-17 (1991), MeFerling, Chicago Tribune, Dec. 18, 1998 MePartland etal lr Ther, §, 57-62 (1990), Mishkin et aly Proc. Soc Exp. Biol, Med., 185, 41-48 (1987), Mon et al. Biochem. Pharmacol, 30, 31-43 (198) Mon et al. Biochem. Pharmacol. 30, 45-58 (1981). Morse etal, Life Sei. 56, 1957-62 (1995), Nahas et al, Fed. Pro., 36, 1748-52 (1977) Nahas et al, Pharmacology, poster session 1848, Nathan et al, Cam. Physiol. Pharmacol, 70, 1308-1308 (1992), Noe et al, Drugs of Abuse, Inmunomodulation and AIDS, 25, 223-24 (Plenum Press, 198), Now etal. Advances in Experimental Medicine and Biology, 437, 223-29 (1998), Novak etal, farahedron Let, 283-$4 (1982). ‘Ongradi et al, Patho! Oncol Res. 4, 191-199 (1998), Papahatjs et al, J. Med. Chem, 41, 1195-200 (1998). (i990, Clin. Pharmacol. Ther, 18, 720-26 ars ota, J. Med. Chem, 19, 455-53 (1976). ate, J. Int Hemp. Assoe., 2, 74.76 (1095). Pearce et al, J. of Med. Chem., 37, 826-541 (1994) Penglis etal, J. Immunol, 165, 3, 1605-1611 (2000), Petite etal, Life Sei. 63, PL 1-6 (1998) Pillai etal veh Tacol, 68, 609-617 (1991), Piomelli, Nat Med., 6, 255-56 (2000), Polansky etal, “Eivosanoid preduetion and ylucocorticoid regulatory mechanisms jn eultuted human trabecular mesh- ‘work eels, "Abstract, NIH Grant No, 25081211190017695. Pop, Cur. Op. Chem. Biol. 3, 418-425 (1998), Promes etal, Emergency Medicine Report, 19, 24, 258-268 (1998) Razdan etal, J. Med. Chem. 19, 454-60 (1976), Rardan, Pharmacolog Rev. 38, 75-148 (1986). Razdan, “Synthesis of Tetrahydrocannabino/related com- pounds.” Abstract, NIH Grant No. SROIDADSAS8-12. Reggio et al, J. Med. Chem. 40, 3812-18 (1997), Rega et al Life Se, $6, 2025-32 (199) Rhee et al. J Med. Chem, 40, 3228-33 (1997), Rhee et al. J. Newroohem. 71, 1525-34 (1998), Ritch, Current Opinion in Ophthalmology, U1 (2000), Rome otal, Proc. Nat. Acad. Sci, 72, 4863-486 (1975), Ross etal, Br J. Pharmacol. 126, 665-72 (1998). Scannell etal, J. Am. Chem: Soe:, 110, 3651-83 (1988). Schuel etal, Marihuana and Medicine, (1999). Seltzman, Cur Med. Chem, 6, 685-704 (1999), Shen et al, Prostaglandin Synthetase Inhibitors, 19-31

    Das könnte Ihnen auch gefallen